Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products

Products

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DC48586 Lalistat 2 Featured
Lalistat 2 is a specific inhibitor of lysosomal acid lipase (LAL) with no effect on other forms of lipase.
More description
DC31014 GMB-475 Featured
GMB-475 is a degrader of BCR-ABL1 tyrosine kinase based on PROTAC, overcoming BCR-ABL1-dependent drug resistance. GMB-475 targets BCR-ABL1 protein and recruits the E3 ligase Von Hippel Lindau (VHL), resulting in ubiquitination and subsequent degradation of the oncogenic fusion protein[1].
More description
DC11022 OUL35 Featured
OUL35 (NSC39047) is a potent and selective inhibitor of mono-ADP-ribosyltransferase PARP10/ARTD10 with IC50 of 330 nM, displays remarkable selectivity towards ARTD10 over other enzymes in the human protein family.
More description
DC66323 WAY-270252 Featured
IGF-1R/SRC inhibitor
More description
DC66321 WAY-328141 Featured
useful for the treatment of cystic fibrosis; modulating CFTR activity; altering the lifespan of a eukaryotic organism;
More description
DC66320 WAY-301122 Featured
cytotoxity (targeted to DNA topoisomerase II); anti-cancer activity; fungicides;
More description
DC66319 WYE-176249 Featured
VEGF inhibitor
More description
DC66318 WAY-301522 Featured
DC35842 6-Maleimidocaproic acid Featured
6-Maleimidocaproic acid contains a maleimide group and a terminal carboxylic acid. The terminal carboxylic acid can be reacted with primary amine groups in the presence of activators (e.g. EDC, or DCC) to form a stable amide bond. The maleimide group will react with a thiol group to form a covalent bond, enabling the connection of biomolecule with a thiol.
More description
DC74098 NOX-6-18 Featured
NOX-6-18 is a potent, selective GPR132 antagonist with IC50 of 17 nM.
More description
DC8002 CPI-360 (R) Featured
CPI-360 is a compound in design and preparation of wew palladium precatalysts for C-C and C-N cross-coupling reactions.
More description
DC66316 BMS-P5 HCl Featured
BMS-P5 is a Novel Peptidylarginine Deiminase 4 (PAD4) Inhibitor with pIC50 values in the range of 5-​7.5. BMS-P5 Blocks Formation of Neutrophil Extracellular Traps and Delays Progression of Multiple Myeloma. Administration of BMS-P5 to multiple myeloma-bearing mice delays appearance of symptoms and disease progression Targeting PAD4 may be beneficial for treatment of multiple myeloma.
More description
DC57082 MC-MMAE Featured
Mc-MMAE is a protective group (maleimidocaproyl)-conjugated monomethyl auristatin E (MMAE), which is a potent tubulin inhibitor. Mc-MMAE is a drug-linker conjugate for ADC.
More description
DC66315 WAY-326101 Featured
glucocerebrosidase activator;
More description
DC66314 WAY-310301 Featured
anti-inflammatory, COX inhibitory activities and ulcerogenic liability
More description
DC66313 WAY-301158 Featured
antitubercular activity; fungicidal activity;
More description
DC34347 AG1478 HCl Featured
AG1478 HCl is an inhibitor of epidermal growth factor receptor protein.
More description
DC66312 DB2313 HCl Featured
DB2313 is a first-in-class potent small-molecule inhibitor of PU.1. DB2313 disrupts the interaction of PU.1 with target gene promoters and leads to down-regulation of canonical PU.1 transcriptional targets.
More description
DC66311 BRD4 Inhibitor-24 Featured
BRD4 Inhibitor-24 (compound 3U) is a potent BRD4 inhibitor, BRD4 Inhibitor-24 shows antitumor activity against MCF7 and K652 cells, with IC50 values of 33.7 and 45.9 μM, respectively.
More description
DC66310 WAY-388798 Featured
DC66309 NFATc1-IN-1 Featured
NFATc1-IN-1 (compound A04) is a potent inhibitor of RANKL-induced osteoclast formation, with an IC50 of 1.57 μM. NFATc1-IN-1 shows anti-osteoclastogenic effects through reducing the RANKL-induced nuclear translocation of NFATc1. NFATc1-IN-1 can be used for osteoclastic diseases research.
More description
DC66308 WAY-299775 Featured
potential leads for chaperone therapy for Gaucher disease
More description
DC12625 MitoBloCK-10 Featured
MitoBloCK-10 (MB-10) is a potential attenuator of protein import into mitochondria via targeting Tim44, inhibits the import of substrates that use the TIM23 import pathway.
More description
DC66307 WAY-328168 Featured
antagonist of the NK3 receptor; altering the lifespan of a eukaryotic organism;
More description
DC66306 WAY-328182 Featured
restore E-cadherin expression in the SW620 colon adenocarcinoma cell line
More description
DC66305 WAY-328133 Featured
useful for the treatment of cystic fibrosis
More description
AES-350 AES-350 Featured
AES-350 is a potent and orally active HDAC6 inhibitor with an IC50 and a Ki of 0.0244 μM and 0.035 μM, respectively. AES-350 is also against HDAC3, HDAC8 in an enzymatic activity assay with IC50 values of 0.187 μM and 0.245 μM, respectively. AES-350 triggers apoptosis in AML cells through HDAC inhibition and can be used for acute myeloid leukemia (AML) research.
More description
DC9476 NBD-556 Featured
NBD-556 is small molecule mimetic of CD4, NBD-556 recognizes the HIV-1 envelope protein gp120 and induces restructuring of gp120 analogous to CD4 binding.
More description
DC71650 BVDV IN-1 Featured
BVDV IN-1 is a non-nucleoside inhibitor of bovine viral diarrhea virus (BVDV), with an EC50 of 1.8 μM.
More description
DC11053 GAK inhibitor 49 Featured
GAK inhibitor 49 is a potent, selective, ATP-competitive inhibitor of cyclin G-associated kinase (GAK, cell IC50=56 nM) with favourable NAK family selectivity (AAK1, STK16, BMP2K).
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X